Literature DB >> 7960609

Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.

D H Shevrin1, T E Lad, P Guinan, L J Kilton, A Greenburg, P Johnson, R R Blough, H Hoyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7960609     DOI： 10.1007/BF00873239

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  5 in total

1.  Structure of quinomycin antibiotics.

Authors:  D G Martin; S A Mizsak; C Biles; J C Stewart; L Bacynsky; P A Meulman
Journal:  J Antibiot (Tokyo)       Date:  1975-04       Impact factor: 2.649

2.  Echinomycin: a bifunctional intercalating antibiotic.

Authors:  M J Waring; L P Wakelin
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  DNA bis-intercalation: application of theory to the binding of echinomycin to DNA.

Authors:  R H Shafer; M J Waring
Journal:  Biopolymers       Date:  1980-02       Impact factor: 2.505

4.  Cytotoxic activity of echinomycin in a human tumor cloning system.

Authors:  B Lathan; D D Von Hoff
Journal:  Cancer Drug Deliv       Date:  1984

5.  Phase I study of echinomycin administered on an intermittent bolus schedule.

Authors:  J H Harvey; M McFadden; W G Andrews; P J Byrne; J D Ahlgren; P V Woolley
Journal:  Cancer Treat Rep       Date:  1985-12
  5 in total
  8 in total

1.  Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer.

Authors:  Christopher M Bailey; Yan Liu; Gong Peng; Huixia Zhang; Miao He; Duxin Sun; Pan Zheng; Yang Liu; Yin Wang
Journal:  Nanomedicine       Date:  2020-07-30       Impact factor: 5.307

2.  Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells.

Authors:  Yin Wang; Yan Liu; Fei Tang; Kelsie M Bernot; Reuven Schore; Guido Marcucci; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2014-07-03       Impact factor: 22.113

3.  A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma. An Illinois Cancer Center Study.

Authors:  W J Gradishar; N J Vogelzang; L J Kilton; S J Leibach; A W Rademaker; S French; A B Benson
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

4.  Quinomycin A reduces cyst progression in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Emily A Daniel; Jessica Y Idowu; Wei Wang; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

5.  Examination of the relationship between viscoelastic properties and the invasion of ovarian cancer cells by atomic force microscopy.

Authors:  Mengdan Chen; Jinshu Zeng; Weiwei Ruan; Zhenghong Zhang; Yuhua Wang; Shusen Xie; Zhengchao Wang; Hongqin Yang
Journal:  Beilstein J Nanotechnol       Date:  2020-04-06       Impact factor: 3.649

6.  Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic.

Authors:  Caixia Chen; Xiangyin Chen; Biao Ren; Hui Guo; Wael M Abdel-Mageed; Xueting Liu; Fuhang Song; Lixin Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

7.  Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma.

Authors:  Walhan Alshaer; Manar Zraikat; Amer Amer; Hamdi Nsairat; Zainab Lafi; Dana A Alqudah; Enas Al Qadi; Tasneem Alsheleh; Fadwa Odeh; Arwa Alkaraki; Malek Zihlif; Yasser Bustanji; Elias Fattal; Abdalla Awidi
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

8.  Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.

Authors:  Sivapriya Ponnurangam; Prasad R Dandawate; Animesh Dhar; Ossama W Tawfik; Rajashri R Parab; Prabhu Dutt Mishra; Prafull Ranadive; Rajiv Sharma; Girish Mahajan; Shahid Umar; Scott J Weir; Aravind Sugumar; Roy A Jensen; Subhash B Padhye; Arun Balakrishnan; Shrikant Anant; Dharmalingam Subramaniam
Journal:  Oncotarget       Date:  2016-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.